
Traspect-MF 500mg/250mg Tablet
Marketer
Indospectrum Pharmaceuticals Pvt. Ltd.
Salt Composition
Tranexamic Acid (500mg) + Mefenamic Acid (250mg)
Overview Traspect-MF 500mg/250mg Tablet
Combifem 500mg/250mg tablets are prescribed for managing heavy menstrual bleeding and associated pain. This medication works by inhibiting clot breakdown, thus reducing excessive menstrual flow. It also suppresses the production of pain-inducing and inflammatory mediators. The tablets can be ingested with food at any time, ideally consistently at the same time daily. For optimal efficacy, initiate treatment on the first day of menstruation. Continue use as directed by your physician, adhering strictly to the prescribed dosage and duration. If a dose is missed, take it immediately upon recollection. Complete the entire course, even with symptom improvement. If no improvement in menstrual bleeding is observed after three consecutive cycles, inform your doctor. Commonly reported side effects encompass nausea, abdominal discomfort, headache, nasal congestion, sinusitis, skin rashes, fatigue, and musculoskeletal pain. Diarrhea may also occur; increased fluid intake is recommended to prevent dehydration. Consult your physician if menstrual bleeding remains unchanged after three cycles. Prior to commencing treatment, disclose any kidney issues, vaginal bleeding disorders, pregnancy, or breastfeeding to your doctor. All other medications should also be reported. Regular eye examinations may be required during treatment. Alcohol consumption should be avoided while using this medication.
Uses of Traspect-MF 500mg/250mg Tablet
Managing excessive menstrual flow and menstrual discomfort
Major Benefits of Traspect-MF 500mg/250mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Traspect-MF 500mg/250mg tablets with a meal.
Common Side effects of Traspect-MF 500mg/250mg Tablet:
- Nausea
- Vomiting
- Heartburn
- Indigestion
- Diarrhea
- Loss of appetite
- Nasal congestion (stuffy nose)
- Headache
- Tiredness
- Musculoskeletal (bone, muscle or joint) pain
- Anemia (low number of red blood cells)
- Stomach pain
- Sinus pain
- Sinus inflammation
How to use Traspect-MF 500mg/250mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Traspect-MF 500mg/250mg Tablet should be administered with a meal.
How Traspect-MF 500mg/250mg Tablet works:
Each Traspect-MF 500mg/250mg tablet unites Tranexamic Acid and Mefenamic Acid, two distinct medications. Tranexamic Acid, an antifibrinolytic agent, stabilizes blood clots, thereby reducing menstrual bleeding. Mefenamic Acid, a non-steroidal anti-inflammatory drug (NSAID), inhibits prostaglandin synthesis, mitigating pain and inflammation characterized by redness and swelling.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Traspect-MF 500mg/250mg tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Traspect-MF 500mg/250mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Based on available data, the use of Traspect-MF 500mg/250mg tablets while breastfeeding appears to pose minimal risk to the infant. Limited human studies indicate negligible infant harm.
DrivingUNSAFE
Taking Traspect-MF 500mg/250mg tablets might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Traspect-MF 500mg/250mg tablets, as dose modification may be necessary. Consult a physician before use. Traspect-MF 500mg/250mg tablets are contraindicated in individuals with severe renal dysfunction.
LiverSAFE IF PRESCRIBED
Use of the medication Traspect-MF 500mg/250mg Tablet in patients with liver conditions appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary, however, medical advice is strongly recommended.
What if you forget to take Traspect-MF 500mg/250mg Tablet :
Should you forget to take your Traspect-MF 500mg/250mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Traspect-MF 500mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | KINSHIP |
